Gastrointestinal development and meeting the nutritional needs of premature infants

American Journal of Clinical Nutrition

Volumn 85, Issue 2, 2007, Pages

  Neu, Josef ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b NONE   (United States)

Author keywords

Developmental gastroenterology; Intestinal growth; Microecology; Necrotizing enterocolitis; Premature infants

Indexed keywords

DEXAMETHASONE; PROBIOTIC AGENT;

ATROPHY; CEREBRAL PALSY; CONFERENCE PAPER; DISEASE PREDISPOSITION; DRUG MEGADOSE; ENTERIC FEEDING; ENTEROPATHY; GASTROINTESTINAL TRACT; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTESTINE; INTESTINE ATROPHY; INTESTINE MOTILITY; MEDICAL RESEARCH; MOTOR ACTIVITY; NECROTIZING ENTEROCOLITIS; NEONATOLOGY; NONHUMAN; NUTRITIONAL INTOLERANCE; NUTRITIONAL REQUIREMENT; ORGANOGENESIS; PARENTERAL NUTRITION; PREMATURITY; SEPSIS;

EID: 33846872130     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.2.629s     Document Type: Conference Paper

References (77)

1. Bell MJ, Rudinsky M, Brotherton T, Schroeder K, Boxerman SB. Gastrointestinal microecology in the critically ill neonate. J Pediatr Surg 1984;19:745-51.
2. Israel EJ. Neonatal necrotizing enterocolitis, a disease of the immature intestinal mucosal barrier. Acta Paediatr Suppl 1994;396:27-32.
3. Kliegman RM, Fanaroff AA. Necrotizing enterocolitis. N Engl J Med 1984;310:1093-103.
4. Kreft B, Dalhoff K, Sack K. Necrotizing enterocolitis: a historical and current review. Med Klin (Munich) 2000;95:435-41.
5. Martinez-Tallo E, Claure N, Bancalari E. Necrotizing enterocolitis in full-term or near-term infants: risk factors. Biol Neonate 1997;71:292-8.
6. Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone treatment in extremely-low-birth- weight infants. N Engl J Med 2001;344:95-101.
7. Okuyama H, Kubota A, Oue T, Kuroda S, Ikegami R, Kamiyama M. A comparison of the clinical presentation and outcome of focal intestinal perforation and necrotizing enterocolitis in very-low-birth-weight neonates. Pediatr Surg Int 2002;18:704-6.
8. Berseth CL. Gastrointestinal motility in the neonate. Clin Perinatol 1996;23:179-90.
9. Newell SJ, Booth IW, Morgan ME, Durbin GM, McNeish AS. Gastrooesophageal reflux in preterm infants. Arch Dis Child 1989;64:780-6.
10. Berseth CL. Gestational evolution of small intestine motility in preterm and term infants. J Pediatr 1989;115:646-51.
11. Neu J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am 1996;43:409-32.
12. Kliegman RM. Models of the pathogenesis of necrotizing enterocolitis. J Pediatr 1990;117:S2-5.
13. Neu J. Functional development of the fetal gastrointestinal tract. Semin Perinatol 1989;13:224-35.
14. Neu J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am 1996;43:409-32.
15. Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr 1999;158:S18-22.
16. Speer CP. Pre- and postnatal inflammatory mechanisms in chronic lung disease of preterm infants. Paediatr Respir Rev 2004;5:S241-4.
17. Liu Z, Li N, Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr 2005;94:386-93.
18. Hyman PE, Clarke DD, Everett SL, et al. Gastric acid secretory function in preterm infants. J Pediatr 1985;106:467-71.
19. Antonowicz I, Lebenthal E. Developmental pattern of small intestinal enterokinase and disaccharidase activities in the human fetus. Gastroenterology 1977;72:1299-303.
20. Guillet R, Stoll BJ, Cotten CM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics [serial online] 2006;117:e137-42. Internet: http://pediatrics.aappublications.org/cgi/content/full/117/2/e137 (accessed 19 December 2006).
21. Beach RC, Menzies IS, Clayden GS, Scopes JW. Gastrointestinal permeability changes in the preterm neonate. Arch Dis Child 1982;57:141-5.
22. Roberton DM, Paganelli R, Dinwiddie R, Levinsky RJ. Milk antigen absorption in the preterm and term neonate. Arch Dis Child 1982;57:369-72.
23. Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 2000;279:G851-7.
24. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003;6:6-23.
25. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci U S A 2000;97:6043-8.
26. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counter-inflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999;103:766-71.
27. Halpern MD, Holubec H, Dominguez JA, et al. Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res 2002;51:733-9.
28. Teitelbaum JE, Walker WA. Review: the role of omega 3 fatty acids in intestinal inflammation. J Nutr Biochem 2001;12:21-32.
29. Dilsiz A, Ciftci I, Aktan TM, Gurbilek M, Karagozoglu E. Enteral glutamine supplementation and dexamethasone attenuate the local intestinal damage in rats with experimental necrotizing enterocolitis. Pediatr Surg Int 2003;19:578-82.
30. Amin HJ, Zamora SA, McMillan DD, et al. Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr 2002;140:389-91.
31. Millar M, Wilks M, Costeloe K. Probiotics for preterm infants? Arch Dis Child Fetal Neonatal Ed 2003;88:F354-8.
32. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292:1115-8.
33. Sanderson IR, Naik S. Dietary regulation of intestinal gene expression. Annu Rev Nutr 2000;20:311-38.
34. Yoo J, Nichols A, Mammen J, et al. Bryostatin-1 enhances barrier function in T84 epithelia through PKC-dependent regulation of tight junction proteins. Am J Physiol Cell Physiol 2003;285:C300-9.
35. Haller D, Bode C, Hammes WP, Pfeifer AMA, Schiffrin EJ, Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 2000;47:79-87.
36. Neish AS The gut microflora and intestinal epithelial cells: a continuing dialogue. Microbes Infect 2002;4:309-17.
37. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 2002;99:15451-5.
38. Porter EM, Bevins CL, Ghosh D, Ganz T. The multifaceted Paneth cell. Cell Mol Life Sci 2002;59:156-70.
39. Bell MJ, Shackelford P, Feigin RD, Ternberg JL, Brotherton T. Epidemiologic and bacteriologic evaluation of neonatal necrotizing enterocolitis. J Pediatr Surg 1979;14:1-4.
40. Kosloske AM. Epidemiology of necrotizing enterocolitis. Acta Paediatr Suppl 1994;396:2-7.
41. Takeda K, Kaisho T. Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76.
42. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41.
43. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115:1-4.
44. Vinderola G, Matar C, Perdigon G. Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors. Clin Diagn Lab Immunol 2005;12:1075-84.
45. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192-6.
46. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-9.
47. Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut 2005;54:317-20.
48. Bach JF. A Toll-like trigger for autoimmune disease. Nat Med 2005;11:120-1.
49. Kohse KP, Carl A, Steinbach G. Whole blood interleukin-8 concentrations in capillary and cord blood of neonates for the diagnosis of systemic inflammatory states. Clin Lab 2002;48:497-503.
50. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999;3:197-202.
51. Robertson AF, Baker JP. Lessons from the past. Semin Fetal Neonatal Med 2005;10:23-30.
52. Philip AGS. The evolution of neonatology. Pediatr Res 2005;58:799-815.
53. Zhang L, Li N, Caicedo R, Neu J. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-α-induced interleukin-8 production in Caco-2 cells. J Nutr 2005;135:1752-6.
54. Petrof EO, Kojima K, Ropeleski MJ, et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 2004;127:1474-87.
55. Berger RE. Lactobacillus sepsis associated with probiotic therapy. J Urol 2005;174:1843.
56. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005;24:278-80.
57. Wagner RD, Warner T, Roberts L, Farmer J, Balish E. Colonization of congenitally immunodeficient mice with probiotic bacteria. Infect Immun 1997;65:3345-51.
58. Martin R, Langa S, Reviriego C, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 2003;143:754-8.
59. Martin R, Olivares M, Marin ML, Fernandez L, Xaus J, Rodriguez JM. Probiotic potential of 3 Lactobacilli strains isolated from breast milk. J Hum Lact 2005;21:8-17.
60. Caicedo RA, Schanler RJ, Li N, Neu J. The developing intestinal ecosystem: implications for the neonate. Pediatr Res 2005;58:625-8.
61. Pessi T, Sutas Y, Saxelin M, Kallioinen H, Isolauri E. Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbiol 1999;65:4725-8.
62. Dotan I, Rachmilewitz D. Probiotics in inflammatory bowel disease: possible mechanisms of action. Curr Opin Gastroenterol 2005;21:426-30.
63. Ouwehand AC, Tolkko S, Kulmala J, Salminen S, Salminen E. Adhesion of inactivated probiotic strains to intestinal mucus. Lett Appl Microbiol 2000;31:82-6.
64. Neu J, Caicedo R. Probiotics: protecting the intestinal ecosystem? J Pediatr 2005;147:143-6.
65. Kliegman RM, Willoughby RE. Prevention of necrotizing enterocolitis with probiotics. Pediatrics 2005;115:171-2.
66. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002;82:103-8.
67. Bell EF. Preventing necrotizing enterocolitis: what works and how safe? Pediatrics 2005;115:173-4.
68. Kudsk KA. Current aspects of mucosal immunology and its influence by nutrition. Am J Surg 2002;183:390-8.
69. Wildhaber BE, Yang H, Spencer AU, Drongowski RA, Teitelbaum DH. Lack of enteral nutrition-effects on the intestinal immune system. J Surg Res 2005;123:8-16.
70. Buchman AL, Moukarzel AA, Bhuta S, et al. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr 1995;19:453-60.
71. Neu J, Zhang L. Feeding intolerance in very-low-birthweight infants: what is it and what can we do about it? Acta Paediatr Suppl 2005;94:93-9.
72. Owens L, Burrin DG, Berseth CL. Minimal enteral feeding induces maturation of intestinal motor function but not mucosal growth in neonatal dogs. J Nutr 2002;132:2717-22.
73. Burrin DG, Stoll B, Guan X, Cui L, Chang X, Holst JJ. Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. Endocrinology 2005;146:22-32.
74. Hirai C, Ichiba H, Saito M, Shintaku H, Yamano T, Kusuda S. Trophic effect of multiple growth factors in amniotic fluid or human milk on cultured human fetal small intestinal cells. J Pediatr Gastroenterol Nutr 2002;34:524-8.
75. Mariadason JM, Kilias D, Catto-Smith A, Gibson PR. Effect of butyrate on paracellular permeability in rat distal colonic mucosa ex vivo. J Gastroenterol Hepatol 1999;14:873-9.
76. Little D, Dean RA, Young KM, et al. PI3K signaling is required for prostaglandin-induced mucosal recovery in ischemia-injured porcine ileum. Am J Physiol Gastrointest Liver Physiol 2003;284:G46-56.
77. Wu G, Jaeger LA, Bazer FW, Rhoads JM. Arginine deficiency in preterm infants: biochemical mechanisms and nutritional implications. J Nutr Biochem 2004;15:442-51.